Contribution of IL22 to experimental skin inflammation

Progress in Inflammation Research: ‘IL17, IL22 and Their Producing Cells: Role in Inflammation and Autoimmunity’, Springer Basel, 305‐317.

LECRON JC., PARIS I., BERNARD FX., MOREL F. (2013)

Laboratoire Inflammation, Tissus Epithéliaux et Cytokines, UPRES EA4331, Pôle Biologie Santé, Université de Poitiers, France.
CHU de Poitiers, France.
Bioalternatives, Gençay, France.

Abstract

The skin represents the first line defense against various stresses including pathogens and injuries. Cutaneous homeostasis and defenses are maintained by permanent cross talk among dermal fibroblasts, keratinocytes, and cells of the immune system residing in or recruited to skin, through the production of cytokines and chemokines. In this chapter, we discuss the biological effects of IL22 on keratinocytes and more particularly its position in skin inflammation and in the development of inflammatory skin diseases such as psoriasis.
Focused on in vitro human models, we present the mechanisms of action of IL22 as well as its involvement in structure, metabolism, differentiation, chemotaxis, antibacterial activity, innate immunity, and tissue remodeling of epidermis. Pertinence of these models is debated by confrontation to structural and molecular characteristic of psoriatic skin. IL22 belongs to cytokine milieu impregnating inflammatory skin. We attempt to delineate more precisely its unique position among other proinflammatory cytokines and in the synergistic effect of these cytokines. Finally, we consider the local cell sources of IL22 in the psoriatic skin.
We question potential new therapeutic strategies for psoriasis focused on more specific and downstream targets, i.e., keratinocyte-targeting cytokines, rather than on modulating producing cells by immunosuppression.

© Springer International Publishing AG, Part of Springer Science+Business Media

KEYWORDS: Immunology; Receptors; Cytokines and Growth Factors ; Infectious Diseases; Cancer Research

Check out Bioalternatives’ updates and experience new testing ideas

  • Bioassays, models and services
  • Posts and publications
  • Events

Related Posts or publications

Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis Acute-serum Amyloid A (A-SAA), one of the major acute-phase proteins, is mainly produced in the liver but extra-hepatic synthesis involving the skin has been reported. Its expression is regulated by the transcription factors NF-κB, C/EBPβ, STAT3 acti...
Imiquimod-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome The pathogenesis of inflammatory skin diseases such as psoriasis involves the release of numerous proinflammatory cytokines, including members of the IL-1 family. Here we report overexpression of IL-1α, IL-1β, and IL-1 receptor antagonist mRNA, assoc...
IL22/IL-22R pathway induces cell survival in human glioblastoma cells Interleukin-22 (IL-22) is a member of the IL-10 cytokine family that binds to a heterodimeric receptor consisting of IL-22 receptor 1 (IL-22R1) and IL-10R2. IL-22R expression was initially characterized on epithelial cells, and plays an essential rol...
Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M This study highlights the precise role of cytokines in the skin inflammatory response (psoriasis). IL-22 and OSM more specifically drive epidermal hyperplasia and differentiation loss while IL-1α, IL-17A and TNFα were more involved in the activation ...
Involvement of IL-1 and Oncostatin M in acanthosis associated with hypertensive leg ulcer Hypertensive leg ulcer (HLU) is an inflammatory disease characterized by intense pain, alteration of vascularization, and skin necrosis. The optimal treatment relies on surgical removal of necrotic tissues covered by a split-skin graft.